LUX Infusion, an ambulatory infusion center (AIC) with three clinics across Alaska, delivers standard and specialty infusions, as well as injectable therapies for acute and chronic care patients. To build a strong, scalable revenue cycle foundation and support fast growth, they partnered with Prochant to tackle:
- Manual claim corrections that masked true adjustment rates
- Delays in authorizations affecting patient care and referral relationships
- Complex credentialing and coding requirements specific to AICs
- The need for a partner to manage long-term growth
By leveraging Prochant Pulse™, Prochant’s proprietary technology, along with the expertise of their dedicated RCM and EVPA teams, the partnership achieved significant results:
- 400% increase in revenue
- 52.3% reduction in DSO within 1 year
- 33% decrease in denials over 8 months
- 15.6% A/R >90 maintained despite a 3x increase in volume
With automated processes, real-time dashboards and specialized support, LUX Infusion now processes claims more efficiently, maintains financial stability and can continue to scale operations without sacrificing patient care.
See how Prochant helped a startup AIC establish a strong RCM foundation and drive sustainable growth. Access the full case study to learn more.
Frequently Asked Questions
1. What revenue cycle challenges do ambulatory infusion centers (AICs) typically face?
Ambulatory infusion centers often struggle with manual claim corrections, complex credentialing, delays in prior authorizations, and coding requirements unique to infusion services. These issues can reduce cash flow, increase denials, and create barriers to growth.
2. How did Prochant help LUX Infusion improve revenue cycle performance?
Prochant provided specialized RCM and EVPA teams supported by Prochant Pulse™, their proprietary technology. This combination streamlined claims processing, reduced denials, and accelerated payments, giving LUX Infusion the ability to scale without sacrificing patient care.
3. What measurable results were achieved through this AIC case study?
Within one year, LUX Infusion saw a 400% revenue increase, a 52.3% reduction in DSO, a 33% decrease in denials, and A/R >90 kept steady at 15.6% despite a 3x increase in patient volume.
4. Why is outsourcing revenue cycle management important for ambulatory infusion centers?
Outsourcing RCM allows infusion providers to access specialized expertise, advanced technology, and dedicated teams that reduce administrative burden. This helps centers stay compliant, improve collections, and focus on delivering quality patient care while maintaining financial stability.
5. Can other ambulatory infusion centers replicate LUX Infusion’s success with Prochant?
Yes. Prochant partners with AICs and home infusion providers nationwide, offering tailored RCM strategies and scalable technology. By aligning processes and performance goals, other centers can achieve similar improvements in revenue growth and operational efficiency.
